PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 102 filers reported holding PROVENTION BIO INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,712,916 | +1587.2% | 320,038 | +640.0% | 0.00% | – |
| Q4 2022 | $457,142 | +217.5% | 43,249 | +35.4% | 0.00% | – |
| Q3 2022 | $144,000 | +11.6% | 31,952 | -1.0% | 0.00% | – |
| Q2 2022 | $129,000 | -50.6% | 32,278 | -9.4% | 0.00% | – |
| Q1 2022 | $261,000 | +22.5% | 35,618 | -6.0% | 0.00% | – |
| Q4 2021 | $213,000 | -3.6% | 37,876 | +9.9% | 0.00% | – |
| Q3 2021 | $221,000 | -29.2% | 34,473 | -6.9% | 0.00% | – |
| Q2 2021 | $312,000 | -35.4% | 37,028 | -19.5% | 0.00% | – |
| Q1 2021 | $483,000 | -18.5% | 45,993 | +31.4% | 0.00% | – |
| Q4 2020 | $593,000 | +7.6% | 34,996 | -18.6% | 0.00% | – |
| Q3 2020 | $551,000 | -16.5% | 43,002 | -8.1% | 0.00% | – |
| Q2 2020 | $660,000 | +177.3% | 46,793 | +81.1% | 0.00% | – |
| Q1 2020 | $238,000 | -23.5% | 25,835 | +24.0% | 0.00% | – |
| Q4 2019 | $311,000 | +270.2% | 20,839 | +68.5% | 0.00% | – |
| Q3 2019 | $84,000 | +663.6% | 12,369 | +334.0% | 0.00% | – |
| Q3 2018 | $11,000 | – | 2,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |